Comparison of the induction of SOS repair in Escherichia coli PQ37 and PQ243 by antineoplastic agents

Acta Poloniae Pharmaceutica - Drug Research

Volumn 54, Issue 1, 1997, Pages 35-41

  Marczewska, Jadwiga ^a   Koziorowska, Jadwiga ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

Alkylating drugs; E. coli PQ37 and PQ243; SOS Chromotest

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; LOMUSTINE; MELPHALAN; MESYLIC ACID METHYL ESTER; METHYLNITRONITROSOGUANIDINE; STREPTOZOCIN;

ARTICLE; CONTROLLED STUDY; DNA REPAIR; ESCHERICHIA COLI; GENOTOXICITY; METABOLIC ACTIVATION; NONHUMAN; SOS CHROMOTEST;

ANTINEOPLASTIC AGENTS, ALKYLATING; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; LAC OPERON; LOMUSTINE; MELPHALAN; MICROBIAL SENSITIVITY TESTS; MUTAGENICITY TESTS; SOS RESPONSE (GENETICS); STREPTOZOCIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031052951     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Quillardet P., Huisman O., D'Ari R., Hofnung M.: Proc. Natl. Acad. Sci. USA. 79, 5971 (1982).
2. Quillardet P., Hofnung M.: Mutation Res. 297, 235 (1993).
3. Huisman O., D'Ari R.: Nature 290, 797 (1981).
4. Boiteux S., Huisman O., Laval L.: Embo J. 3, 2569 (1984)
5. Quillardet P., Hofnung M.: Mutation Res. 147, 65 (1985).
6. Evensen G., Seeberg E.: Nature 296, 773 (1982).
7. Karran P., Hjelmgren T., Lindahl T.: Nature 296, 770 (1982).
8. Costa de Oliveira R., Laval J., Boiteux S.: Mutation Res. 183, 11 (1986).
9. Czeczot H., Kusztelak J.: Acta Biochim. PoIon. 40, 549 (1993).
10. Quillardet P., Hofnung M.: Mutation Res. 205, 107 (1988).
11. Quillardet P., de Bellecombe CH., Hofnung M.: Mutation Res. 147, 79 (1985).
12. IARC. International Agency for Research on Cancer, Lyon. IARC Monographs Volumes 1-29, Suppl. 4 (1982).
13. Marczewska J., Chłopkiewicz B., Ejchart A., Koziorowska J.: Acta Microbiol. Polon. 42, 2, 205 (1993).
14. Mamber S.W., Okasinski W.G., Pinter Ch.D., Tunac J.B.: Mutation Res. 171, 83 (1986).
15. Le Curieux F., Marzin D., Erb F.: Mutation Res. 319, 223 (1993).
16. Calabresi P., Chabner B.A. in: A. Goodman Gilman, T.W. Rall, A.S. Nies and P. Taylor (Eds.), The Pharmacological Basis of Therapeutics, Pergamon Press, pp. 1209 (1991).
17. Colvin M.: in: Chabner B.A., (Eds.), Pharmacologic Principles of Cancer Treatment, Philadelphia, pp. 276 (1982).
18. Maron D.M., Ames B.N.: Mutation Res. 113, 173 (1983).
19. Schacterle G.R., Pollack R.L.: Anal. Biochem. 51, 654 (1973).
20. Eder E., Favre A., Deiniger C., Hahn H., Kütt W.: Mutagenesis 4, 179 (1989).
21. Hill-Perkins M., Jones M.D., Karran P.: Mutation Res 162, 153 (1986).
22. Druckrey H., Kruse H., Preussmann R., Ivancovic S., Landschütz Ch.: Cancerogene alkylierende Substanzen. III Alkyl-halonide,-sulfate, sulfonate and ringgespannte Heterocyclen, Z. Krebsforsch, 73, 241 (1970).